Universal Biosensors, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UBI.AX research report →
Price Chart
About the company
Established in 2001 and headquartered in Rowville, Australia, Universal Biosensors, Inc. , through its subsidiary Universal Biosensors Pty Ltd, operates as a specialized biosensor technology company. Its core business involves the creation, production, and market introduction of point-of-use devices designed to measure analytes across diverse industries.
- CEO
- Salesh Balak
- IPO
- 2006
- Employees
- 76
- HQ
- Rowville, VIC, AU
Get TickerSpark's AI analysis on UBI.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.17M
- P/E
- -0.40
- PEG
- 0.02
- P/S
- 1.51
- P/B
- 0.59
- EV/EBITDA
- -0.50
- Div Yield
- 0.00%
- Gross Margin
- -13.15%
- Op Margin
- -404.29%
- Net Margin
- -378.10%
- ROE
- -101.41%
- ROIC
- -90.27%
Latest fiscal year · YoY change
- Revenue
- $6.28M-5.3%
- Gross Profit
- $4.00M-6.6%
- Op Income
- $-16,968,464
- Net Income
- $-14,239,743-111.2%
- EPS
- $-0.05-66.2%
- OCF Growth
- +15.9%
- FCF Growth
- +21.0%
- 52W High
- $0.16
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.06
- Beta
- 0.22
- RSI (14)
- 31
- Avg Volume
- 282.81K
No earnings-call transcripts are available for UBI.AX yet.
- Free Float
- 86.5%
- Shares Outstanding
- 298.07M
- Float Shares
- 257.89M
Our UBI.AX coverage
Recent articles, reports, and earnings notes.
No research on UBI.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate UBI.AX report →